Indian drug maker Sun Pharmaceutical Industries reported a steeper-than-expected 67% drop in first quarter consolidated net profit, hurt by lower sales of finished drugs and regulatory problems in the U.S., more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment